Mirum Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:08D Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
27 Mar 24	Buy€45,840	Eric Bjerkholt	Individual	2,000	€22.92
25 Mar 24	Sell€102,458	Peter Radovich	Individual	4,303	€23.81
18 Mar 24	Buy€47,462	Eric Bjerkholt	Individual	2,000	€23.73
02 Feb 24	Sell€145,947	Christopher Peetz	Individual	6,013	€24.27
02 Feb 24	Sell€29,466	Pamela Vig	Individual	1,214	€24.27
02 Feb 24	Sell€43,447	Peter Radovich	Individual	1,790	€24.27
02 Feb 24	Sell€20,558	Lara Longpre	Individual	847	€24.27
08 Jan 24	Sell€133,066	Christopher Peetz	Individual	5,209	€25.55
08 Jan 24	Sell€35,967	Pamela Vig	Individual	1,408	€25.54
08 Jan 24	Sell€35,967	Peter Radovich	Individual	1,408	€25.55
08 Jan 24	Sell€26,031	Lara Longpre	Individual	1,019	€25.55
13 Sep 23	Buy€75,782	Frazier Life Sciences Management, LP	Company	2,625	€28.87
12 Sep 23	Buy€239,355	Frazier Life Sciences Management, LP	Company	8,437	€28.53
11 Sep 23	Buy€275,886	Eric Bjerkholt	Individual	10,000	€27.59
31 Aug 23	Buy€40,303,716	Frazier Life Sciences Management, LP	Company	1,667,294	€24.20
31 Aug 23	Buy€3,581,752	Frazier Life Sciences Management, LP	Company	147,991	€24.20
25 Aug 23	Sell€84,228	Jolanda Howe	Individual	3,459	€24.35
03 Jul 23	Sell€129,217	Christopher Peetz	Individual	5,498	€23.50
03 Jul 23	Sell€23,597	Lara Longpre	Individual	1,004	€23.50
03 Jul 23	Sell€33,491	Peter Radovich	Individual	1,425	€23.50
03 Jul 23	Sell€33,491	Pamela Vig	Individual	1,425	€23.50

Insider Trading Volume

Insider Buying: 08D insiders have sold more shares than they have bought in the past 3 months.

Ownership Breakdown

What is the ownership structure of 08D?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	4,240	0.008%
State or Government	39,154	0.0739%
Individual Insiders	944,008	1.78%
Hedge Funds	4,370,024	8.25%
VC/PE Firms	6,495,392	12.3%
Institutions	41,124,421	77.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 23.9%.

Top Shareholders

Top 25 shareholders own 85.67% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
13.8%	Frazier Life Sciences Management, LP	6,495,392	€155.7m	0.39%	6.83%
9.27%	BVF Partners L.P.	4,370,024	€104.8m	0%	2.63%
5.65%	Eventide Asset Management, LLC	2,663,649	€63.9m	-32.7%	1.15%
5.26%	The Vanguard Group, Inc.	2,476,244	€59.4m	46.2%	no data
5.22%	BlackRock, Inc.	2,461,750	€59.0m	16.5%	no data
4.38%	Janus Henderson Group plc	2,062,551	€49.5m	7.21%	0.02%
4.11%	Cadian Capital Management, LP	1,934,922	€46.4m	34.9%	1.95%
3.93%	Rock Springs Capital Management LP	1,851,464	€44.4m	1.69%	1.29%
3.68%	State Street Global Advisors, Inc.	1,734,775	€41.6m	7.02%	no data
3.18%	Novo Holdings A/S	1,500,000	€36.0m	0%	0.02%
3.06%	Citadel Advisors LLC	1,442,812	€34.6m	-16%	0.04%
2.47%	T. Rowe Price Group, Inc.	1,164,682	€27.9m	3,540%	no data
2.43%	Avidity Partners Management, L.P.	1,142,850	€27.4m	0%	1.1%
2.41%	Tang Capital Management, LLC	1,137,107	€27.3m	0%	3.0%
2.03%	First Turn Management, LLC	958,654	€23.0m	14.6%	3.89%
1.94%	Franklin Resources, Inc.	912,575	€21.9m	22.6%	0.01%
1.91%	Medical Strategy GmbH, Asset Management Arm	898,782	€21.6m	0%	1.34%
1.68%	Pictet Asset Management Limited	793,655	€19.0m	7.39%	0.01%
1.54%	Norges Bank Investment Management	727,684	€17.4m	0%	no data
1.45%	Geode Capital Management, LLC	681,180	€16.3m	18.5%	no data
1.33%	William Blair Investment Management, LLC	627,272	€15.0m	0.88%	0.02%
1.33%	Polar Capital Holdings Plc	625,000	€15.0m	-46.8%	0.07%
1.26%	AXA Investment Managers S.A.	593,713	€14.2m	-3.79%	0.03%
1.22%	Adage Capital Management, L.P.	575,000	€13.8m	-13.5%	0.03%
1.14%	Perceptive Advisors LLC	534,942	€12.8m	-20.4%	0.31%